MedTrace Logo

A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up

NCT05123287 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-11-17

No results posted yet for this study

Summary

A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up

Conditions

  • Plaque, Atherosclerotic
  • Immune Checkpoint Inhibitors
  • Programmed Cell Death Protein 1 Inhibitor
  • Carotid Artery Plaque
  • Intimal Medial Thickness of Internal Carotid Artery

Interventions

DRUG

PD-1 immune checkpoint blockades

intravenous injection; frequency: 2-3 weeks/cycle; duration: 3 months

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Jianan Wang, MD, PhD · 2nd Affiliated Hospital, School of Medicine at Zhejiang University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-08
Primary Completion
2022-06-01
Completion
2022-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05123287 on ClinicalTrials.gov